Tags : Frank Gerhard

Corporate Regulatory

Homburger advises PHOENIX on its joint venture with Voigt Group

PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding announced that they agreed to establish a 50/50-joint venture to combine their pharmaceutical distribution services and pre-wholesale activities. The closing of the joint venture is subject to the approval by the Swiss Competition Commission. Homburger has advised PHOENIX Pharma Switzerland on the […]

Deal & transactions

Homburger advises DKSH on the acquisition of Terra Firma

DKSH Holding has acquired Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its performance materials business unit platform to the US and Canada. The transaction is an important step in DKSH’s strategy to build a global distribution platform for specialty chemicals and ingredients. The transaction, which is […]

Banking & Finance

Homburger advises Addex Therapeutics on new PIPE transaction

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 4,500,000 shares in the form of 750,000 American Depositary […]

Deal & transactions

Homburger advises BlackFin Capital Partners on the sale of New

BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access is primarily active in the markets of Switzerland, Liechtenstein and Luxembourg. These markets are key to serving and administering client wealth globally […]

Deal & transactions

Homburger advised DKSH in its Acquisition of the Refarmed Group

DKSH Holding has announced the acquisition of Swiss Refarmed Group, strengthening its capabilities in the life sciences. Through the acquisition, DKSH Business Unit Performance Materials, the leading global distributor of innovative pharmaceutical ingredients synthesis and formulation with vast and constantly growing global geographic reach, obtains a uniquely positioned business which provides value-added products and services […]

Deal & transactions

Homburger advises Addex Therapeutics on new PIPE transaction 

Allosteric modulation company Addex Therapeutics has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares («ADSs») at a gross purchase price of USD 6.50 per ADS, which is equivalent to CHF 1.00 per share. Each ADS represents six shares.   Additionally, Addex has […]

Capital Markets

Oviva raises USD 80m in Series C financing round. The

Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round was co-led by Sofina and Temasek, alongside existing investors AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, and several […]